Filip M, Nowak E, Papla I
Department of Pharmacology, Institute of Pharmacology Polish Academy of Science, Krakow, Poland.
J Physiol Pharmacol. 2001 Sep;52(3):471-81.
Apart from showing involvement of dopamine, recent studies also indicate a role of serotonin (5-HT) in the behavioral effects of cocaine in rodents. In the present study we investigated the role of 5-HT2A/2C receptors in the development or expression of sensitization to cocaine in rats, using ketanserin, an antagonist at these receptors. Since ketanserin also shows a high affinity for alpha1-adrenoceptors, prazosin, a comparative antagonist at those receptors was also examined. Male Wistar rats were treated repeatedly (for 5 days) with cocaine (10 mg/kg) in combination with either vehicle, or ketanserin (1-3 mg/kg) or prazosin (3 mg/kg); afterwards, on day 10, they received a challenge dose of cocaine (10 mg/kg). In another experiment, the animals were given either with vehicle or cocaine (10 mg/kg) for 5 days, and were then challenged with cocaine (10 mg/kg) in combination with vehicle, or ketanserin (1-3 mg/kg) or prazosin (3 mg/kg) on day 10. Acute administration of cocaine increased the locomotor activity in rats; that hyperactivation was inhibited by ketanserin (3 mg/kg), but not by prazosin. In animals treated repeatedly with cocaine, the locomotor hyperactivity induced by a challenge dose of the psychostimulant was ca. 2-3 times higher than that after its first administration. No difference was observed in the response to cocaine challenge in rats treated repeatedly with cocaine, ketanserin+cocaine, or prazosin+cocaine. In animals treated repeatedly with the psychostimulant, the behavioral response to a challenge dose of cocaine was dose-dependently decreased when the drug was combined with ketanserin, but not with prazosin. The above findings indicate a role of 5-HT2A/2C receptors (but not alpha1-adrenoceptors) in the acute locomotor hyperactivity, as well as in the expression (but not development) of cocaine sensitization. Since chronic use of cocaine by humans may lead to psychoses or craving for this drug of abuse, our findings also seem to indicate possible importance of 5-HT2A/2C receptor antagonists in the therapy of cocaine addiction.
除了表明多巴胺的参与外,最近的研究还表明血清素(5-羟色胺,5-HT)在可卡因对啮齿动物行为的影响中发挥作用。在本研究中,我们使用酮色林(这些受体的拮抗剂)研究了5-HT2A/2C受体在大鼠对可卡因敏化的形成或表达中的作用。由于酮色林对α1-肾上腺素能受体也表现出高亲和力,因此还研究了哌唑嗪(这些受体的比较拮抗剂)。雄性Wistar大鼠反复(持续5天)接受可卡因(10毫克/千克)与溶剂、或酮色林(1-3毫克/千克)或哌唑嗪(3毫克/千克)的联合治疗;之后,在第10天,它们接受一剂可卡因(10毫克/千克)的激发剂量。在另一个实验中,动物连续5天给予溶剂或可卡因(10毫克/千克),然后在第10天用溶剂、或酮色林(1-3毫克/千克)或哌唑嗪(3毫克/千克)与可卡因(10毫克/千克)联合进行激发试验。急性给予可卡因可增加大鼠的运动活性;该过度激活被酮色林(3毫克/千克)抑制,但未被哌唑嗪抑制。在反复用可卡因治疗的动物中,精神兴奋剂激发剂量诱导的运动性多动比首次给药后高约2-3倍。在用可卡因、酮色林+可卡因或哌唑嗪+可卡因反复治疗的大鼠中,对可卡因激发试验的反应未观察到差异。在用精神兴奋剂反复治疗的动物中,当药物与酮色林联合使用时,对可卡因激发剂量的行为反应呈剂量依赖性降低,但与哌唑嗪联合使用时则不然。上述发现表明5-HT2A/2C受体(而非α1-肾上腺素能受体)在急性运动性多动以及可卡因敏化的表达(而非形成)中发挥作用。由于人类长期使用可卡因可能导致精神病或对这种滥用药物的渴望,我们的发现似乎还表明5-HT2A/2C受体拮抗剂在可卡因成瘾治疗中可能具有重要意义。